Group | Number of subjects | Number of subjects with seizure disorders | Percentage of subjects with seizure disorders | AEDs used (number of subjects) | p-value for seizure disorders | p-value for AEDs | Test method |
---|---|---|---|---|---|---|---|
A | 11 | 7 | 63.6% | VPA (3), LEV (3), TPX (1), OXC (2), CLN (1), LCM (1), CLB (1) | 0.02 vs. H*, 0.34 vs. D | 0.04 vs. H*, 0.12 vs. D | Chi-square |
H | 47 | 19 | 40.4% | VPA (6), LEV (11), TPX (1), OXC (5), PB (4), CLN (7), LMT (2), LCM (1) | 0.02 vs. A*, 0.09 vs. D | 0.04 vs. A*, 0.07 vs. D | Chi-square |
D | 15 | 9 | 60.0% | VPA (7), LEV (3), TPX (3), OXC (1), CLN (3), LCM (1), VGB (3), PRG (1), CLB (1) | 0.34 vs. A, 0.09 vs. H | 0.12 vs. A, 0.07 vs. H | Chi-square |